MindWalk Holdings Corp.

NASDAQ:HYFT

Biotechnology

Healthcare
$1.08 +0.33%

+$0.01 today

Market cap
$50.88M
Beta
0.82
P/E (TTM)
-8.1
EPS (TTM)
-$0.26
52W Low $0.82High $3.25

Volume 0.20M

Average 0.32M

HYFT Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

MindWalk Holdings Corp.NASDAQ: HYFT

Weighted Avg Shares (Diluted) · Q3 FY2026 · quarter ended Jan 2026

Weighted avg shares (diluted) grows, but more slowly than its trailing trend

Q3 FY2026 weighted avg shares (diluted) of 46.52M shares rose 41.6% year over year, behind the +43.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.8% from the prior quarter. Over 3 fiscal years it compounded at +19.2% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +41.6% toward the trailing-twelve-month pace of +43.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJan 2026
46.52M+0.8% QoQ
Last fiscal yearApr 2025
33.39M+30.2% YoY
LTMJan 2026
41.36M+43.8% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+41.6%——
1 year+30.2%——
3-year CAGR+19.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
33.39M CAD
Year-over-year change
+30.2%
4-year CAGR
+19.3%

Weighted Avg Shares (Diluted) vs competitors

How HYFT compares with its peers on the latest reported figures

  • HYFT's LTM Jan 2026 weighted avg shares (diluted) of 41.36M shares is the 6th highest of the 9 companies compared; the peer median is 60.12M shares.
  • Its year-over-year change of +43.8% is the 4th highest of 9, against a peer median of +40.4%.
  • Over three fiscal years its annual growth of +19.2% compares with a peer median of +44.6%.
HYFT Competitors Peer median
Weighted Avg Shares (Diluted) for HYFT and competitors
Company Period LTM YoY 3-year CAGR
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026107.08M +1045.8%+372.5%
ATYRaTyr Pharma, Inc.LTM Mar 202695.83M +20.8%+48.5%
FBIOFortress Biotech, Inc.LTM Mar 202695.09M +349.0%+261.1%
GUTSFractyl Health, Inc. Common StockLTM Mar 202666.33M +37.1%+16.8%
ALXOALX Oncology Holdings Inc.LTM Mar 202653.9M +2.3%+9.7%
HYFTMindWalk Holdings Corp.LTM Jan 202641.36M +43.8%+19.2%
BYSIBeyondSpring Inc.LTM Mar 202640.54M +2.1%+1.1%
CAMPCAMP4 Therapeutics CorporationLTM Mar 202637.54M +102.0%—
CLNNClene Inc.LTM Mar 202610.33M +43.6%+44.6%
Peer median (excluding HYFT) 60.12M+40.4%+44.6%

Competitors are the stored peer set for HYFT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Revenue17.91M19.36M20.67M24.52M24.52M
Cost of Revenue6.37M8.38M9.1M12.47M10.97M
Gross Profit11.54M10.98M11.56M12.05M13.55M
Gross Margin64.4%56.7%56.0%49.2%55.3%
Research & Development1.97M7.66M14.1M4.04M4.94M
Selling, General & Admin13.27M18.06M18.99M19.14M19.03M
Operating Expenses15.71M27.66M37.17M25.82M25.74M
Depreciation & Amortization3.71M3.77M6.69M5.74M5.12M
EBITDA(1.42M)(11.99M)(21.04M)(22.95M)(28.86M)
EBITDA Margin-7.9%-61.9%-101.8%-93.6%-117.7%
Operating Income(4.18M)(16.67M)(25.61M)(13.76M)(12.2M)
Operating Margin-23.3%-86.1%-123.9%-56.1%-49.7%
Interest Income265.01K279K122K23K0
Interest Expense602.37K85K30K19K9.91K
Other Income / Expenses(1.82M)825K(2.14M)(14.94M)(22.07M)
Income Before Tax(6M)(15.85M)(27.75M)(28.7M)(34.27M)
Pre-Tax Margin-33.5%-81.8%-134.3%-117.1%-139.8%
Income Tax Expense1.35M861K(1.19M)(2.59M)(4.03M)
Net Income(7.34M)(16.71M)(26.56M)(26.12M)(30.23M)
Net Margin-41.0%-86.3%-128.5%-106.5%-123.3%
EPS (Basic)(0.45)(0.87)(1.07)(1.03)(0.90)
EPS (Diluted)(0.45)(0.87)(1.07)(1.03)(0.90)
Weighted Avg Shares16.47M19.69M24.9M25.64M33.39M
Weighted Avg Shares (Diluted)16.47M19.69M24.9M25.64M33.39M

MindWalk Holdings Corp.

NASDAQ:HYFT

Intrinsic Alpha fair value

Locked

Current Price

$1.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.